1. Home
  2. ENTA vs FPH Comparison

ENTA vs FPH Comparison

Compare ENTA & FPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$10.94

Market Cap

303.8M

Sector

Health Care

ML Signal

N/A

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

N/A

Current Price

$4.48

Market Cap

300.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ENTA
FPH
Founded
1995
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
303.8M
300.7M
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
ENTA
FPH
Price
$10.94
$4.48
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $21.83
N/A
AVG Volume (30 Days)
244.8K
★ 283.5K
Earning Date
11-24-2026
10-22-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.93
N/A
EPS
N/A
★ N/A
Revenue
$102,814,000.00
★ $110,020,000.00
Revenue This Year
N/A
$1,459.63
Revenue Next Year
N/A
$5.38
P/E Ratio
★ N/A
$11.40
Revenue Growth
★ 16.48
N/A
52 Week Low
$10.01
$4.02
52 Week High
$17.15
$6.47

Technical Indicators

Market Signals
Indicator
ENTA
FPH
Relative Strength Index (RSI) 45.83 52.50
Support Level $10.01 $4.11
Resistance Level $13.94 $4.64
Average True Range (ATR) 0.80 0.17
MACD 0.08 0.05
Stochastic Oscillator 41.51 70.27

Price Performance

Historical Comparison
ENTA
FPH

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

Share on Social Networks: